retatrutide clinical trials safety efficacy PDF) and of for overweight/obesity or type 2 diabetes: a systematic review and meta-analysis Starting Phase 3b Clinical Trial

The brain pathway may be more significant than the endocrine route for the physiological effects of GLP-1, especially regarding insulin release, but the endocrine route becomes more pronounced with bigger meals and more L-cell activation (Deacon 2019)

Ideal for patients on the lowest dose who want to maintain weight loss results or benefit from additional wellness support

In theory, transdermal delivery can be effective, but it depends on the substance

This reflects multiple growth drivers and an expanding therapeutic reach across diabetes, obesity, and adjacent indications

Thats a conversation, not a dead end

As in adults, gastrointestinal adverse effects were commonly seen